HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Dorte Nielsen(Herlev Hospital), Claus Kamby(University of Copenhagen), Michael Andersson(University of Copenhagen)
Cited by 134
Related Papers
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
|JAMA|2003|659
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
|Journal of Clinical Oncology|2010|600
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
|Journal of Clinical Oncology|2002|564
Serum YKL-40, A New Prognostic Biomarker in Cancer Patients?
|Cancer Epidemiology Biomarkers & Prevention|2006|364